Amgen has finally put an end to weeks of rumours and speculations
by admitting its plans to slash 12-14 per cent of its workforce to
offset the recent difficulties it has been facing with the sales of
its anaemia blockbusters.
Pfizer was taken by surprise this week as a US engineering firm
announced that it had been awarded a contract to manage
construction of the firm's proposed biotech production plant in
Ireland, before the plant plans themselves...
The often cited decline in R&D productivity and dwindling
innovation within the pharma industry is actually a thing of the
past, according to Wyeth's head of business development.
The pharmaceutical industry has come up top in the most
Intellectual Property (IP)-intensive industry in the US, according
to a report released this week.
PerkinElmer has expanded its multi-vendor service offering to help
firms reduce the cost of regulatory compliance in pharmaceutical
drug development and manufacturing quality control laboratories.
Targeted Genetics said it was 'premature as well as irresponsible'
to draw any conclusions on what caused the death of a patient who
participated in a clinical trial testing the safety of the firm's
new gene therapy.
A US bankruptcy court judge ruled on Friday that Puerto Rican-based
pharma services firm Inyx USA be put under the control of an
independently-appointed trustee.
Kuehne + Nagel (K + N) has inked a new pact with UK-based drug
maker AstraZeneca to provide the global cold chain air and sea
freight for some of its products.
In the latest episode of illegal drug trading, a hoard of
unlicensed medicines was seized by the UK Medicines and Healthcare
products Regulatory Agency (MHRA) last week, taken from a London
lock-up containing a stash of various male...
In a round-up of motley pharmaceutical services news,
Outsourcing-Pharma takes a look at recent announcements involving
Quintiles, Kenexa, Atos, Catalent Pharma, Patni and Taratec.
The latest twists and turns in the Inyx Inc. bankruptcy saga
include an attempted power seize by its creditor, fraud allegations
thrown around courtrooms and in the media, the resignation of Inyx'
accountants, and increasing...
Sanofi Pasteur, Point Therapeutics, Amira Pharmaceuticals, Elusys
Therapeutics and Chesapeake Pharmaceutical Packaging have all had
people on the move in the world of pharmaceutical manufacturing.
The field of oral controlled release drug delivery is constantly
evolving and developing, allowing ever more precise and tailored
delivery profiles for pharmaceutical drugs.
The US Food and Drug Administration (FDA) has released a draft
guideline document outlining a model for implementing the
International Conference on Harmonization's (ICH) Q10.
At a packed out session at last week's Controlled Release Society
meeting in the US, two experts battled it out to win one of the key
debates in gene delivery: which is superior - viral or non-viral
delivery?
Computer giant IBM has re-inked a huge $1.4bn (€1.0bn) IT
outsourcing deal with drug giant AstraZeneca, who is continuing its
cost-cutting drive to become 'lean and agile'.
As Outsourcing-Pharma.com continues to investigate the
circumstances of the Inyx group's insolvency problems, it can
be revealed that some of the senior management have been
involved at a senior level in other firms that have...
Almost the entire international operations of specialty pharma
contract manufacturer Inyx is facing insolvency and the company is
locked in a legal battle with its principal financier.
Transdermal drug delivery expert Noven Pharmaceuticals is to buy
JDS Pharmaceuticals in a deal worth $125m (€91m) to transform
itself into a 'fully-integrated speciality pharmaceutical company'.
Quintiles' subsidiary Pharmalink has acquired the marketing rights
to Eli Lilly India's flagship antibiotic brand Distaclor (cefaclor)
in a bid to boost its core services business.
NPS Pharmaceuticals, Targanta Therapeutics, Merck & Co., MAP
Pharmaceuticals and Merrimack Pharmaceuticals have all had people
on the move in the world of pharmaceutical manufacturing.
Chiltern, Patheon, Hill Top Research, AMRI, Perceptive Informatics,
Xceleron and Charles River Labs have all had people on the move in
the world of pharmaceutical outsourcing.
Two of the UK's top contract sales organisations (CSO) have merged
to create what is claimed to be the country's leading CSO -
something that is disputed by its nearest rival.
A European regulatory committee has recommended the approval of
three generic versions of Johnson & Johnson's (J&J) anaemia
blockbuster Eprex in what could lead to the market launch of new
"biosimilars" by the...
The International Society for Pharmaceutical Engineering (ISPE) has
published its latest industry guide, a revised edition of its
manual providing industry guidance on facilities and production of
active pharmaceutical ingredients...
Despite a lift of the ban on biological sample transportation out
of Russia, the country's clinical research industry is still in the
dark on the new rules to control export of such materials.
US firm Aptuit has announced it will invest $100m (€75m) in
India-based Laurus Labs to form a new joint venture - just a few
months after splurging a similar amount to expand its capabilities.
Following last year's contaminated glycerin poisonings in Panama
and last month's FDA guidance, US-PharmaTechnologist.com takes a
look at the implications of testing for the excipient glycerin in
the pharmaceutical supply...
In a round-up of motley pharmaceutical services contracts,
Outsourcing-Pharma takes a look at recent news involving Movianto,
PDI, inVentiv Health and Exel.
Relaunching pharmaceutical products in a bid to preserve an earlier
product's existing market share and maintain revenues is a common
tactic in the pharma industry, but, as a recent report notes,
kicking off development plans...
The former director of the country's State Food and Drug
Administration (SFDA) has lodged an appeal against the death
penalty slapped on him after a corruption conviction.
After dismal second quarter results Patheon is stepping up its
resolve for 'damage control' and indicated that further cutbacks at
its problematic Puerto Rico plant are imminent.
Siegfried Generics this week kicked off production at its new
manufacturing facility in Malta making the most of the country's
lack of pharma patents which gives the firm a head-start in
producing generic pharmaceuticals.
The apparent inability of current analytical techniques to fully
characterise complex biological drugs still stands in the way of
easy approval pathways for 'biogenerics' or copies of off-patent
brand name biologics.
Valeant Pharmaceuticals has announced that it has found a buyer for
two of its manufacturing plants in a final move to
complete the restructuring plans announced by the company last
year.
Bionovo, Somaxon Pharmaceuticals, Trius Therapeutics, Exelixis,
AmerisourceBergen Corporation and Kindred Healthcare have all had
people on the move in the world of pharmaceutical manufacturing.
The pharmaceutical and healthcare industries will help to push
trade between India and the United Kingdom up by 60 per cent within
three years, claims a soon-to-be released report.
In a bid to push manufacturers to reduce their greenhouse gas
emissions, the UK government last week unveiled a proposal that
could pave the way for "carbon footprint" labels on products.
Switzerland-based Roche is helping African nations fight the AIDS
epidemic by sharing its coveted saquinavir drug-producing
technology with two more manufacturers in Ethiopia and Zimbabwe.
British drug maker AstraZeneca has awarded UK-based NYK Logistics a
two and a half year contract for the distribution of its drugs
throughout Europe, worth £6m (€8.9m).
